Polyarteritis nodosa primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Polyarteritis nodosa}} | {{Polyarteritis nodosa}} | ||
{{CMG}}; | {{CMG}}; {{AE}} {{CZ}}; [[User:Haritha|Haritha Machavarapu, M.B.B.S.]] | ||
==Overview== | ==Overview== | ||
==Primary Prevention== | ==Primary Prevention== | ||
There is no known prevention. However, early treatment can prevent some damage and symptoms. | There is no known prevention. However, early treatment can prevent some damage and symptoms. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 19:51, 29 June 2016
|
Polyarteritis nodosa Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Polyarteritis nodosa primary prevention On the Web |
|
American Roentgen Ray Society Images of Polyarteritis nodosa primary prevention |
|
Risk calculators and risk factors for Polyarteritis nodosa primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Haritha Machavarapu, M.B.B.S.
Overview
Primary Prevention
There is no known prevention. However, early treatment can prevent some damage and symptoms.